Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy.

Icon for Elsevier Science Related Articles

Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy.

J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4S):S24-S29.e2

Authors: Mooney EV, Hamper JG, Willis RT, Farinha TL, Ricchetti CA

Abstract
OBJECTIVE: To evaluate patient satisfaction with pharmacist-administered long-acting injectable antipsychotics (LAIAs) in the community pharmacy.
DESIGN: Prospective survey.
SETTING: Albertsons Companies community pharmacies during December 2016 to February 2017.
PARTICIPANTS: Patients receiving LAIAs at participating pharmacies.
MAIN OUTCOME MEASURES: A survey assessed patients' satisfaction with pharmacist-administered LAIAs in the community pharmacy.
RESULTS: LAIA recipients (N = 104) reported satisfaction with community pharmacist-administered LAIAs. Participants who had received the service at other types of health clinics (N = 57) also reported higher satisfaction with current service compared to a similar service received elsewhere. Participants indicated that they would recommend service to others and that service was more convenient than a similar service received in an alternative setting. There was not a statistically significant relationship between patient demographic characteristics and likelihood of recommending service to others.
CONCLUSION: Patients were satisfied with a pharmacist-administered LAIA service in the community pharmacy, and they found it more convenient than similar services provided elsewhere.

PMID: 30006184 [PubMed - indexed for MEDLINE]